Oncimmune: Oncimmune Holdings announces major recapitalisation
Oncimmune Holdings, an autoantibody profiling specialist, announced a major recapitalisation to fuel its next growth phase on Friday.
Read full article »
CEO
- -Oncimmune is an England-based biotechnology company that develops an analytical platform for the discovery of immunodiagnostic antibody biomarker signatures.
Read more